Background
==========

Nosocomial infections (NIs) constitute an important health problem with high incidence, morbidity and mortality rates worlwide. NIs have become particularly prominent in intensive care units (ICUs), where the incidence is 2 to 5 times higher than in the general hospitalized population \[[@b1-medscimonit-17-5-ph29]\]. Intensive care unit patients are at greater risk of developing NI because of several reasons including presence of underlying diseases, longer stay, invasive diagnostic and monitoring procedures performed, impaired host defences, and colonization by resistant microorganisms.

Determination of risk factors for developing infection in ICU patients is an important step for implementation of necessary precautions for prevention of infection. Initial empirical antimicrobial treatment should be targetted against the most likely local pathogens, when a NI is suspected. Therefore, the major concern of our study was the prospective assesment of the etiology and risk factors of NIs in the ICU of our hospital during a 1-year period.

Material and Methods
====================

We conducted a 1-year prospective cohort study of nosocomial infection surveillance in a total 25-bed combined medical and surgical ICU of the Kartal Teaching and Research Hospital, which is a 700-bed teaching hospital in Istanbul, Turkey. Infection surveillance was implemented for all patients staying longer than 48 hours in the ICU during the study period from January 1, 2008, to December 31, 2008. Patients coming from ICUs of other hospitals or transferred to the ICU from another clinic in the same hospital, or staying less than 48 hours in the ICU were excluded. A total of 450 patients were included in the study.

Hematological and biochemical tests were performed for all patients once daily. Chest radiography was performed two times a week. Deep tracheal aspirate and urine samples were taken for culture on admission and repeated once a week. Blood samples and/or removed intravascular catheter tips were cultured upon suspicion of bloodstream or catheter-related infection (i.e., fever, leucocytosis). Any other samples (from wounds, cerebrospinal fluid, etc.) were taken for culture when necessary on clinical indication. An infectious diseases specialist regularly visited the ICU daily, followed all the patients there and collected data such as age, gender, cause of ICU admission, underlying diseases, applied invasive procedures (nasogastric tube, endotracheal intubation, mechanical ventilation, tracheotomy, urinary and intravenous catheterization, surgical operation), the Acute Physiology and Chronic Health Evaluation II (APACHE II) score, length of stay, drug use, results of cultures, and administered antibiotics. By means of the CDC definitions of nosocomial infections \[[@b2-medscimonit-17-5-ph29]\], the decision of NI was made with a combination of both clinical evidence and laboratory findings. An appropriate antimicrobial therapy was administered to the patients based on local surveillance data and antibiotic susceptibility patterns of isolated microorganisms. The nosocomial infection rate was calculated as the number of all infections per 100 patients and per 1000 patient-days.

Samples were cultured for isolation of bacteria using standard microbiological methods. Isolated bacteria were identified by conventional methods and tested for antibiotic susceptibility by the Kirby-Bauer disc diffusion technique according to Clinical and Laboratory Standards Institute (CLSI) specifications \[[@b3-medscimonit-17-5-ph29]\]. For each case of ICU-acquired nosocomial infection, the responsible microorganisms were recorded. Only the initial isolates were considered in the study and repeat isolates from the same sites were excluded.

Microbiologically documented BSI required 1 of the following: 1) recognized pathogen in the blood and pathogen not related to an infection at another site; or 2) fever, chills, or hypotension and any of the following:

a.  a common skin contaminant isolated from at least 2 blood cultures drawn on separate occasions, and the organism is not related to infection at another site;

b.  a common skin contaminant is isolated from blood culture in a patient with an intravascular device, and the physician institutes appropriate antimicrobial therapy \[[@b2-medscimonit-17-5-ph29]\].

Risk factors for nosocomial infection were recorded as age, sex, cause of admission to the ICU, the Acute Physiology and Chronic Health Evaluation II (APACHE II) score of patients on admission to the ICU, any underlying diseases, surgical history, use of H~2~ receptor antagonists, central and/or peripheral intravenous access, nasogastric or endotracheal intubation, mechanical ventilation, urinary catheter, tracheostomy, and the length of stay in the ICU.

Statistical analysis
--------------------

Statistical analysis was done with SPSS (Statistical Package for Social Sciences) software, version 10.0 (*SPSS*). Chi-square test, Mann-Whitney U test and logistic regression analysis tests were used. All p values \<0.05 were considered significant.

Results
=======

A total of 1134 patients were admitted to our ICU during the study period. The data collected in this study belonged to 450 patients who stayed \>48 h in the ICU with 6257 patient-days during one year. Of the 450 patients, only 115 patients acquired nosocomial infections and the remaining 335 patients were non-infected. Of the 450 patients, aged between 6 months and 91 years, 267 (59.3.%) were male and 183 (40.7%) were female. The median age was 47.25±23.17 years. There were no significant differences in age and gender between patients with or without ICU-acquired nosocomial infections. Of the 450 patients, only 160 (35.5%) patients had one or more underlying diseases. The most frequent underlying diseases were neoplasia, neurological disease and chronic obstructive pulmonary disease. No significant difference was observed when infected and non-infected cases were compared in terms of underlying diseases (p=0.07). The most frequent causes of admission to ICU were respiratory failure (31.1%), trauma (24.7%) and neurologic disease (22.9%) ([Table 1](#t1-medscimonit-17-5-ph29){ref-type="table"}).

The APACHE-II scores ranged between 5 and 40, with a median of 20.46±5.6, with no significant difference between infected and non-infected patients (p=0.26)

Duration of stay in the ICU was between 3 and 165 days, with a median of 15.45±19.18 days in total study patients, 33.92±27.02 days in the infected patients, and 8.12±6.08 days in the non-infected patients. Longer ICU stay was a significant risk factor for development of NI (p=0.00).

A total of 135 nosocomial infections were detected in 115 (25.6%) of 450 patients. The incidence rate of nosocomial infections was 21.6 in 1000 patient-days, and the infection rate of nosocomial infections was 25.6%. The most frequent site of ICU-acquired NI in our study was the bloodstream (49, 36.3%), followed the respiratory system (41, 30.4%), the urinary tract (25, 18.5%), and catheter-related infection was diagnosed only in 10 patients, (7.4%). The distribution of isolated microorganisms by the sites of nosocomial infection is shown in [Table 2](#t2-medscimonit-17-5-ph29){ref-type="table"}. Of all nosocomial infections, 112 (83%) were microbiologically-confirmed (culture-positive) and 23 (17%) were clinically-defined (culture-negative) infections. The pathogens of the culture-confirmed nosocomial infections were Gram-negatives in 77 (68.8%), Gram-positives in 31 (27.6%), and fungi in 4 (3.6%). Among the 112 microorganisms, the most frequently isolated was *Pseudomonas aeruginosa* (28, 25%), followed by *Staphylococcus aureus* (24, 21.4%), *Escherichia coli* (21, 18.7%), *Acinetobacter baumannii* (19, 16.9%), and *Klebsiella spp.* (5, 4.5%).

When the infected and non-infected patients were compared according to risk factors with univariate analysis, there was no significant difference with respect to age, gender, APACHE II scores, surgical history, presence of urinary and/or nasogastric catheters, or use of H~2~ receptor antagonists (p\>0.05). Length of ICU stay, central venous catheterization, mechanical ventilation and tracheostomy were identified as statistically significant risk factors for developing nosocomial infection (p\<0.05). Extrinsic risk factors in infected and non-infected patients are shown in [Table 3](#t3-medscimonit-17-5-ph29){ref-type="table"}.

Discussion
==========

Assesment of infections acquired in ICUs, determination of their risk factors and establishment of correct treatment protocols are crucial steps in prevention and management of infections in ICUs. We planned this prospective surveillance study to determine the incidence, etiology and risk factors for NI in ICU patients at the Kartal Teaching and Research Hospital, Istanbul, Turkey.

In general, ICU-acquired infections constitute 20--25% of all hospital- acquired infections \[[@b4-medscimonit-17-5-ph29]\]. There may be variations in the incidence of ICU infections between centres, depending on the characteristics of patients and ICUs. In a point-prevalence study including 1417 centres in 17 European countries, the infection rate in ICUs was reported to be 20.6%. The infection rates in ICUs in several other studies reported by authors namely were as follows: Legras et al.: 21.6%, Appelgren et al.: 34%, Aly et al.: 10.6%, Ylipatosani et al.: 23.9%, and Urli et al.: 79% \[[@b5-medscimonit-17-5-ph29]--[@b10-medscimonit-17-5-ph29]\]. When we reviewed the rates of nosocomial infections reported in ICUs in our country, they differed from centre to centre. Meriç et al. reported the infection rate as 39.7%, Esen et al. (who reviewed the data of 56 ICUs in a 1-day point-prevelance study) as 48.7%, and Erbay et al. as 26% \[[@b11-medscimonit-17-5-ph29]--[@b13-medscimonit-17-5-ph29]\]. The hospital infection rate per 100 patient admissions in our hospital was calculated as 25.6%.

Certain specific risk factors play important roles in occurance of infections in ICUs. Several studies have determined the risk factors for ICU-acquired infections. Although some studies reported the patient age over 70 and the presence of underlying diseases to be a risk factor \[[@b6-medscimonit-17-5-ph29],[@b14-medscimonit-17-5-ph29]\], the age and underlying diseases of the patients were not statistically significant risk factors for ICU-acquired infections in our study. A positive correlation between rates of nosocomial infections and average length of ICU stay have been reported in various studies \[[@b12-medscimonit-17-5-ph29],[@b14-medscimonit-17-5-ph29]--[@b17-medscimonit-17-5-ph29]\]. In accordance with the results of these studies, length of ICU stay was a significant risk factor for ICU-acquired infection both in univariate and multivariate analyses in our study. Each invasive procedure performed poses a risk of infection. There was a direct correlation between central venous catheterization, tracheostomy, mechanical ventilation and the risk of infection in our study, in agreement with the results of other studies \[[@b7-medscimonit-17-5-ph29],[@b11-medscimonit-17-5-ph29],[@b14-medscimonit-17-5-ph29],[@b18-medscimonit-17-5-ph29]\].

The most commonly reported sites of nosocomial infections in ICUs are the respiratory tract, followed by the urinary tract and the bloodstream, but the distribution of the sites and causes of infection may differ between centres. [Table 4](#t4-medscimonit-17-5-ph29){ref-type="table"} shows the distribution of common NIs reported from ICU studies in various centres. In general, the most common type of infection in ICU is pneumonia, although Markogiannakis et al. reported bacteremia as the most commonly encountered ICU infection followed by pneumonia similar to the results in our study \[[@b8-medscimonit-17-5-ph29],[@b11-medscimonit-17-5-ph29]--[@b13-medscimonit-17-5-ph29],[@b16-medscimonit-17-5-ph29],[@b17-medscimonit-17-5-ph29],[@b19-medscimonit-17-5-ph29]--[@b21-medscimonit-17-5-ph29]\].

Our study revealed an unexpectedly higher frequency of BSI compared to other reports.

The higher occurrence of BSI seems to be closely related to specific and well-known risk factors such as the presence of indwelling venous catheters, and one or more critical underlying condition.

In majority of studies*,* Gram-negative bacteria have been reported as the most common cause of ICU-acquired infections, but there were differences in rates of their distribution at the species level between centres. *Enterobacteriaceae* (25.9%), *P. aeruginosa* (17.2%), *S. aureus* (10.9%) and *Coagulase-negative staphylococcus* (CNS) (4.1%) were the most frequent microorganisms reported by Leon Rosales et al. Similarly, Vincent et al. reported that the most frequent micro-organisms were *Enterobacteriaceae* (34.4%), *S. aureus* (30.1%), *P. aeruginosa* (28.7%), *CNS* (19.1%) and fungi (17.1%) (5,15). In the study of Tennant et al., *P. aeruginosa* (41.3%) was the most common organism, followed by *Acinetobacter spp* (33.5%), CNS (20%) and *Streptococcus group D* (18.7%) (18). Similarly, various studies on ICU infections performed in our country reported that Gram-negative bacteria were the most frequent pathogens causing ICU infections. Data on distribution of micro-organisms frequently isolated by Erbay et al. in ICUs of various Turkish hospitals were as follows: *P. aeruginosa* (22.6%), methicillin-resistant *S. aureus* (22.2%) and *Acinetobacter spp*. (11.9%). Esen et al. reported *P. aeruginosa* (20.8%), *Acinetobacter spp* (18.2%), *S.aureus* (18.2%) and *Klebsiella spp* (16.1%) as the common pathogens. Whereas, *S. aureus* (30.9%), *Acinetobacter spp* (26.8%), *P. aeruginosa* (12.4%) were the most freguent etiologic agents reported by Meriç et al. \[[@b11-medscimonit-17-5-ph29]--[@b13-medscimonit-17-5-ph29]\].

In our study, the most common cause of ICU infections was *P. aeruginosa* (25%), followed by *S. aureus* (21.4%), *E. coli* (18.7%), and *A. baumannii* (16.9%), in decreasing order. The major pathogen causing bloodstream infections was *S. aureus*, whereas in case of pneumonia and urinary tract infection, *P.aeruginosa* and *E.coli,* were the most common bacteria, respectively.

Conclusions
===========

In conclusion, the bloodstream was the most common site of infection in our ICU. Central venous catheterization, mechanical ventilation, tracheostomy and longer stay in ICU were common risk factors for ICU-acquired infections. Etiologic agents, site and rate of ICU-acquired infections differ from centre to centre. Therefore, each hospital should define their own risk factors for infection, regularly conduct surveillence study of the infectious etiologies of NI, and establish prevention and treatment strategies accordingly, in order to improve the quality of health care.

**Source of support:** Departmental sources

###### 

Demographic characteristics, comorbidities and diagnosis on admission of ICU patients.

  -------------------------------------------------------------------------------------------------
                            Infected patients N (%)\   Non infected patients N (%)\   Total N (%)
                            115                        335                            
  ------------------------- -------------------------- ------------------------------ -------------
  Female/male               49/66                      134/201                        450

  Age                                                                                 

   \<20 years               17 (14.8)                  66 (19.7)                      83 (18.4)

   20--40 years             24 (20.8)                  58 (17.3)                      82 (18.2)

   40--60 years             33 (28.7)                  92 (27.5)                      125 (27.8)

   \>60 years               41 (35.7)                  119 (35.5)                     160 (35.6)

  Admission diagnosis                                                                 

   Trauma                   41 (35.7)                  70 (20.9)                      111 (24.7)

   Respiratory failure      34 (29.6)                  106 (31.6)                     140 (31.1)

   Cardiovascular disease   --                         28 (8.4)                       28 (6.2)

   Neurological disease     30 (26.1)                  73 (21.8)                      103 (22.9)

   Intoxication             --                         25 ((7.5)                      25 (5.5)

  Comorbidities                                                                       

   Diabetes mellitus        11 (9.5)                   12 (3.6)                       23 (5.1)

   Cardiovascular disease   7 (6.1)                    13 (3.9)                       20 (4.4)

   COPD                     5 (4.3)                    22 (6.6)                       27 (6)

   Uremia                   5 (4.3)                    16 (4.8)                       21 (4.7)

   Neoplasia                7 ( 6.1)                   32 (9.5)                       39 (8.7)

   Neurological disease     14 (12.2)                  16 (4.8)                       30 (6.7)

   APACHE II Score          20.39±6.59                 20.37±4.92                     
  -------------------------------------------------------------------------------------------------

COPD -- chronic obstructive pulmonary disease.

###### 

Distribution of isolated micro-organisms by the sites of ICU-acquired infection.

                               BSI              Pneumonia        UTI              Central line infection   Other           Total     \%
  ---------------------------- ---------------- ---------------- ---------------- ------------------------ --------------- --------- -----------
  **Gram negative bacteria**                                                                                               **77**    **68.8**
  *P. aeruginosa*              8                9                7                2                        2               28        25.0
  *E. coli*                    5                3                10               1                        2               21        18.7
  *A. baumannii*               9                3                3                1                        3               19        16.9
  *Klebsiella spp*             3                                 2                                                         5         4.5
  *E. cloacae*                 4                                                                                           4         3.6
  **Gram positive bacteria**                                                                                               **31**    **27.6**
  *S. aureus*                  13               3                                 5                        3               24        21.4
  *Enterococcus spp*           3                --               3                1                                        7         6.3
  *Candida spp*                4                --                                                                         **4**     **3.6**
  **Total**                    **49 (36.3%)**   **41 (30.4%)**   **25 (18.5%)**   **10 (7.4%)**            **10 (7.4%)**   **112**   **100.0**

Other: (skin-soft infections 8, meningitis 2); BSI -- bloodstream infection; UTI -- urinary tract infection.

###### 

Extrinsic risk factors of infected and non-infected patients.

                            Infected patients   Non-infected patients   OR     95% CI         p values
  ------------------------- ------------------- ----------------------- ------ -------------- ----------
  Mechanic ventilation      46                  225                     5.80   1.74--19.29    0.00
  Urinary catheterization   115                 257                     1.44   1.35--1.54     0.56
  CVP catheterization       104                 184                     3.95   2.01--7.77     0.00
  NG catheterization        112                 181                     0.61   0.12--3.11     0.68
  Tracheostomy              30                  7                       8.92   3.76--21.1     0.00
  H~2~ antagonist use       114                 334                     0.34   0.02--5.50     0.45
  Operation                 35                  73                      1.33   0.83--2.15     0.26
  Apache II Score           20.39±6.59          20.37±4.92              0.73   0.97--1.11     0.26
  Duration of stay          33.92±27.02         8.12±6.08               1.68   22.49--29.10   0.00

CVP -- Central venous pressure; NG -- nasogastric tube; CI -- confidence interval; OR -- odds ratio.

###### 

Prevalence rates of NIs reported from other studies.

                                                           Pneumonia %   Bloodstream infection %   Urinary tract infection %
  -------------------------------------------------------- ------------- ------------------------- ---------------------------
  Vincent et al. \[[@b16-medscimonit-17-5-ph29]\]          46.9          12.0                      17.6
  Richards et al. \[[@b17-medscimonit-17-5-ph29]\]         27.0          19.0                      31.0
  Richards et al. \[[@b19-medscimonit-17-5-ph29]\]         31.0          14.0                      23.0
  Aly et al. \[[@b8-medscimonit-17-5-ph29]\]               33.0          24.0                      11.0
  Kallel et al. \[[@b20-medscimonit-17-5-ph29]\]           58.2          18.2                      14.5
  Markogiannakis et al. \[[@b21-medscimonit-17-5-ph29]\]   25.3          36.1                      9.5
  Esen et al. \[[@b12-medscimonit-17-5-ph29]\]             28.0          23.3                      15.7
  Erbay et al. \[[@b13-medscimonit-17-5-ph29]\]            40.9          30.2                      23.6
  Meriç et al. \[[@b11-medscimonit-17-5-ph29]\]            35.4          18.2                      11.8
  Our study                                                30.4          36.5                      18.5
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